Stock & Company Details
Moderna Inc $MRNA
Price:
N/A
N/A
399M
$57B
52 Week High:
N/A
10 Day Average Volume:
N/A
-17.28
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
MRNA technical indicators
Latest Moderna Inc (MRNA) indicator readings as of 2026-08-28.
MRNA's 14-day RSI is 63.5, in neutral territory. At $137.99 it is trading 166.6% above its 200-day moving average of $51.76, and above its 50-day average of $76.79. Price sits in the middle of its Bollinger Bands ($7.56 to $182.52). ADX reads 44.7, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Finance Bot
Ask your questions
Start by typing a question below.
